GlassScriptPhysician profile
Brian Allen Levings
NPI 1891718433
$80,104.07
in general payments reported to CMS, 2019-2025
13 companies · $26K in 2025
The $26K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $46.46 · 2021: $1,003 · 2022: $41K · 2023: $1,686 · 2024: $9,734 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $8,384 · Food and Beverage: $2,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,250.00 |
| Travel and Lodging | $8,384.39 |
| Food and Beverage | $2,745.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $77,814.43 | 2021-2025 | |
| Anika Therapeutics, INC. | $1,117.21 | 2021-2025 | Integrity, Revomotion, Tactoset |
| Depuy Synthes Sales INC. | $355.21 | 2019-2022 | |
| Wright Medical Technology, INC. | $181.16 | 2019 | |
| Depuy Synthes Products, INC. | $133.79 | 2022 | |
| Medacta USA, INC. | $133.12 | 2025 | Mecta |
| Medical Device Business Services, INC. | $92.50 | 2019 | |
| Maxx Health INC | $78.27 | 2025 | Summa Ortho Distal Radius 2, Summa Ortho Clavicle |
| Trice Medical, INC. | $61.84 | 2020-2021 | |
| Horizon Therapeutics Plc | $59.26 | 2019 | |
| Stryker Corporation | $30.42 | 2023 | Aequalis Perform Reversed |
| Restor3d, INC. | $26.87 | 2023 | |
| Innovation Technologies INC | $19.99 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Levings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.